Cuba has signed an agreement with Iran which will allow completion of clinical trials of the Soberana 02 vaccine candidate. Soberana (Sovereign) 2, has completed Phase II trials which started on Dec. 22 and will be tested in human trials in around 150,000 people in Havana.
Editorial use only Contact your sales representative for commercial and promotional uses.License this clip
More footage filed by NurPhoto videographers.